Epstein Secrets

spected of having Clostridium difficile associated disease. This is the third test from IMDx to receive FDA clearance within three months for use on Abbott's fully-automatedm2000 system and follows clearances of the IMDx VanR for Abbott m2000 and IMDx Flu A/B and RSV for Abbott m2000 assays. C. diffici

f a successful move into our new corporate headquarters in Waltham, MA, IMDx today announced its third FDA clearance for its C. difficile assay for Abbott m2000 assay. My best, Alice IntelligentMDx Receives FDA Clearance for IMDx C. difficile for Abbott m2000 Assay, Completes Move of Corporate Headq

assay comes at a pivotal time when incidence of C. difficile infection and severity in both hospital and community settings is increasing," says Dr. Alice Jacobs Nesselrodt, Chairman & CEO of IMDx. "Detection of a wide variety of C. difficile strains, including hypervirulent strains, by the IMDx C. difficile

From: Alice Jacobs <I To: Denise Marston <I CC: Denise Marston <I Subject: MDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay Date: Tue, 30 Jul 2013 14:40:22 +0000 Attachments: IMDx VanR for Abbott m2000 FDA clearance_.pdf I hope you are doing well and are hav

rston <I Subject: MDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay Date: Tue, 30 Jul 2013 14:40:22 +0000 Attachments: IMDx VanR for Abbott m2000 FDA clearance_.pdf I hope you are doing well and are having a great summer. I am pleased to announce that IMDx has achieved a pivotal milesto

From: Alice Jacobs <I To: Denise Marston <I CC: Denise Marston <I Subject: MDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay Date: Tue, 30 Jul 2013 14

Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu of Molecular Tests Cambridge, MA January 20, 2011— IMDx (privately held) today announced that they have signe

cleared if for US sales. Early identification of these pathogens can help improve patient healthcare, shorten treatments, and reduce expense," says Alice Jacobs. MD, Chairman & CEO of IMDx. "This agreement, which demonstrates Abbott Molecular's commitment to menu expansion on the m2000 system, will allow cu